Authors outline the efficacy and safety of topical NSAIDs for the treatment of acute and chronic musculoskeletal pain conditions including osteoarthritis.
SP-102 is a dexamethasone sodium phosphate viscous gel formulation that is administered by epidural injection.
The PROGRESS study compared the efficacy and safety of atogepant to placebo in 778 adults with at least a 1-year history of chronic migraine.
Proposed changes dovetail with a nationwide epidemic of opioid use and overdose deaths.
Multimodal nonopioid regimen of NSAIDs and muscle relaxants provides similar or better pain control than opioids in ACL and rotator cuff surgeries.
Diffuse myofascial pain associated with fatigue and poor sleep hygiene have been noted in patients with long-COVID.
Patients with ulcerative colitis (UC) are looking to avoid recurrent flare-ups of the disease, which can cause significant pain and discomfort. What are some notable factors that have an impact on UC flares that health care professionals can explain to their patients?
No differences seen in WOMAC pain at 3 or 12 months with duloxetine added to usual care, or in subgroup with symptoms of centralized pain.
Platelet-rich plasma injections did not significantly improve knee osteoarthritis pain symptoms or joint structure compared with placebo injections in a randomized controlled trial.
Study authors conducted a systematic review and meta-analysis to determine the effect of different exercise treatments on pain intensity in adults with chronic low back pain.
The FDA reports that EaseVRx uses the principles of cognitive behavioral therapy (CBT) and other behavioral therapy techniques to reduce pain and pain interferences.
The October approvals include treatments for acute pain, opioid overdose, dry eye disease, and COVID-19 vaccine for children 5 to 11 years of age.
Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Sixty-six percent of patients randomly assigned to pain reprocessing therapy were pain-free after treatment compared with 20% in placebo group.
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there is no substantial evidence that they directly increase the risk for vascular events.
The American Society of Pain and Neuroscience has published a best practice guideline for the management and reduction of cancer-associated pain.
The approval is supported by data from the phase 3 STOP 301 study, which evaluated the safety and tolerability of Trudhesa in 354 adults with migraine.
The AANA has rebranded as the American Association of Nurse Anesthesiology as part of a yearlong effort designed to advance the science of nurse anesthesiology and advocate for CRNAs.
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
The majority of APRNs report low levels of preparedness in caring for patients with basic chronic or acute pain management needs in their first year of practice.